Cognitive tests for doctors and dating patients are among scenarios in an infographic on issues in physicians’ interactions with one another and patients. Medscape
Author: Medscape
Does Mast Cell Activation Syndrome Underlie Multiple Ills?
There is controversy over the diagnostic criteria, with one proposed definition placing it at the center of many other co-occurring complex, chronic illnesses. Medscape Medical News
Medscape Report: Age-Related Competency Tests Divide Doctors
Physicians weigh in on malpractice, patient gifts, romantic relationships, and more in Medscape’s latest survey. Medscape Medical News
How Pending Federal Bills Targeting PBMs Might Help Patients
Dr Madelaine A. Feldman discusses how bills might affect access to medications, delink drug list prices from PBMs’ income, and redirect drug manufacturers’ price concessions from payers to patients. MDedge
Human Touch in AI: Balancing Technology With Compassion in Patient Care
Can AI enhance patient care without losing the human touch? Explore how physicians can balance AI’s insights with compassionate care. Medscape Oncology
Addressing AI Bias: Building Trust in Data-Driven Medicine
Addressing bias in AI: Learn how crowdsourcing and transparency can help eliminate disparities and improve trust in AI-driven healthcare solutions. Medscape Oncology
AI in Clinical Decision Support: Predictions for Better Care
Discover the potential of AI in clinical decision support and predictive analytics. Could this technology transform your practice? Medscape Oncology
Step Therapy Is Not a Cost Solution, Says Ethicist
Art Caplan discusses the ethics of insurers’ mandates for step therapy. Medscape Business of Medicine
AI in Adult vs Pediatric Cancer: Genomics Shaping Treatment
How is AI being used differently for adults and children in cancer care? Learn how genomics and AI are revolutionizing oncology. Medscape Oncology
Precision vs Personalization: AI’s Role in Tailored Medicine
Personalized vs precision medicine — what’s the difference? Discover how AI is driving more accurate treatments tailored to individual patients. Medscape Oncology
AI in Clinical Trials: Prioritizing Drugs for Faster Approval
Can AI cut down clinical trial timelines? Find out how AI is prioritizing drugs for trials and fast-tracking treatments to patients. Medscape Oncology
Coordinated Care Improves Anterior Uveitis in Children
Pediatric patients with anterior uveitis benefitted from seeing a rheumatologist and ophthalmologist together in one visit, as opposed to having separate visits with each specialist. Medscape Medical News
AI Breakthroughs in Rare Disease Treatment Transforming Care
AI is transforming the way we treat rare diseases. Explore how innovative algorithms are uncovering new treatments with unparalleled speed and precision. Medscape Oncology
AI’s Role in Revolutionizing Drug Repurposing for Impact
Discover how AI is reshaping drug repurposing by analyzing thousands of drugs and diseases in record time. Learn how this game-changing technology is advancing patient care. Medscape Oncology
Diabetic Neuropathy Linked to Dry Eye
Moderate to severe peripheral neuropathy in diabetes may be linked to an increased risk for dry eye disease. Medscape Medical News
In Gene Therapy for RP, LCA, the Earlier, the Better
A real-world study of an FDA-approved gene therapy for inherited retinal disease shows younger patients gain more visual improvements than adults, but doesn’t rule out the procedure for the older people. Medscape Medical News
Infographic: How Paychecks Look for Millennial Doctors
In a recent Medscape survey, US physicians under age 40 reported about 4% higher compensation on average in 2023. Young specialists earned more than primary care physicians. Medscape
Medicare Will Speed Coverage of Some ‘Breakthrough’ Devices
CMS intends to speed payment decisions for as many as five “breakthrough” medical devices a year, potentially getting them to patients earlier. Medscape Medical News
Real-World Results Show Sustainability, Safety of Faricimab
Early results of a real-world study of faricimab demonstrated sustainable improvements in visual acuity and retinal anatomic markers with no new safety concerns. Medscape Medical News
Does One DME Treatment Have Edge in Reducing Hard Exudates?
Hard exudates may help clinicians gauge response to treatment with faricimab or aflibercept, a new study found. Medscape Medical News